Date du début: 1 nov. 2013,
Date de fin: 31 oct. 2017,
Tropical Atlantic climate recently experienced pronounced shifts of great socio-economic importance. The oceanic changes were largest in the eastern boundary upwelling systems. African countries bordering the Atlantic strongly depend upon their ocean - societal development, fisheries, and tourism. They were strongly affected by these climatic changes and will face important adaptation challenges a ...
Date du début: 1 oct. 2013,
Date de fin: 31 mars 2017,
BIOIMAGE-NMD will develop and apply imaging technology to monitor response to novel therapies in neuromuscular diseases (NMD) and will use Duchenne muscular dystrophy (DMD) as an exemplar disease. DMD is well characterised genetically and clinically but to date a disease modifying treatment is not available. One of the most promising developments for future treatment of NMD is RNA modulation throu ...
Date du début: 1 févr. 2014,
Date de fin: 31 janv. 2017,
The infectious diseases burden imposed by the parasites of Trypanosomatidae family represents a huge problem on people’s lives in countries where these diseases are endemic. Problems associated with existing drugs include inefficient delivery, insufficient efficacy, excessive toxicity and increasing resistance. New drugs are urgently needed now and in the foreseeable future. The New Medicine for T ...
Date du début: 1 nov. 2014,
Date de fin: 31 oct. 2016,
"A novel light trapping approach will be developed to enhance the absorption of thin film silicon (Si) solar cells using periodic arrangements of resonant dielectric micro-particles (DMPs) with dimensions on the other of the illuminating wavelengths. The main goal is to construct prototype cells that show enhanced sunlight-to-electricity conversion efficiency due to the action of DMP arrays incorp ...
Date du début: 1 juin 2013,
Date de fin: 31 mai 2016,
"This project builds on results from the TREAT-NMD and BIO-NMD European projects to develop a personalised-medicinal product through to market for the treatment of Duchenne Muscular Dystrophy (DMD). DMD is an inheritable, childhood rare disease that affects approximately 1 in 3,500 newborn boys. This rare disease is caused by mutations in the dystrophin gene, resulting in the absence or defect of ...
Date du début: 1 déc. 2011,
Date de fin: 30 nov. 2014,
The main aim of the NanoSafePACK project is to develop a best practices guide to allow the safe handling and use of nanomaterials in packaging industries, considering integrated strategies to control the exposure to nanoparticles (NP) in industrial settings, and provide the SMEs with scientific data to minimize and control the NP release and migration from the polymer nanocomposites placed on the ...
Date du début: 1 févr. 2008,
Date de fin: 31 janv. 2012,
Serious adverse effects resulting from the treatment with thalidomide prompted modern drug legislation more than 40 years ago. Post-marketing spontaneous reporting systems for suspected adverse drug reactions (ADRs) have been a cornerstone to detect safety signals in pharmacovigilance. It has become evident that adverse effects of drugs may be detected too late, when millions of persons have alrea ...
Un expert peut vous aider dans toutes les phases de développement de votre projet
Bonjour, vous êtes sur la plateforme Région Sud Provence-Alpes-Côte d’Azur dédiée aux programmes thématiques et de coopération territoriale. Une équipe d’experts vous accompagne dans vos recherches de financements.
Contactez la Région Sud Provence-Alpes-Côte d'Azur
Vous pouvez nous écrire en Anglais, Français et Italien